Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2013
12/25/2013EP2675274A1 SORAFENIB DERIVATIVES AS sEH INHIBITORS
12/25/2013EP2569267B1 Improved methods for preparing squalene
12/25/2013EP2526930B1 Vitamin formulation
12/25/2013EP2523958B1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring
12/25/2013EP2516442B1 Pyrrolo[2,3-d]pyrazin-7-yl pyrimidine compounds
12/25/2013EP2503999B1 Pharmaceutical composition comprising propofol
12/25/2013EP2498771B1 Use of bethanechol for treatment of xerostomia
12/25/2013EP2493845B1 Substituted 3-phenylpropionic acids and the use thereof
12/25/2013EP2493573B1 Use of ferroquine in the treatment of malaria
12/25/2013EP2488514B1 Indole and azaindole modulators of the alpha 7 nachr
12/25/2013EP2483278B1 Benzoxazepin pi3k inhibitor compounds and their use in the treatment of cancer
12/25/2013EP2468729B1 Novel indazole derivative
12/25/2013EP2416794B1 Plant composition for the treatment or prevention of viral blood-borne diseases caused by the human immunodeficiency virus (hiv) or hepatitis c
12/25/2013EP2414365B1 SUBSTITUTED [1,2,4¨TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
12/25/2013EP2406266B1 7-cycloalkylaminoquinolones as gsk-3 inhibitors
12/25/2013EP2406248B1 Novel isoindolin-1-one derivative
12/25/2013EP2397487B1 Short-chain cationic polyamino acid and use thereof
12/25/2013EP2391627B1 Bicyclic pyrazolo-heterocycles
12/25/2013EP2365974B1 Fluorinated benzothiazole derivatives, preparation method thereof and imaging agent for diagnosing altzheimer's disease using the same
12/25/2013EP2359827B1 Adhesive material containing 5-methyl-1-phenyl-2-(1h)-pyridone
12/25/2013EP2358703B1 Tetrasubstituted pyridazines hedgehog pathway antagonists
12/25/2013EP2350311B1 Diacylglycerol acyltransferase inhibitors
12/25/2013EP2344459B1 2,3-substituted indazole or 4,5,6,7-tetrahydro-indazoles as fxr modulators against dyslipidemia and related diseases
12/25/2013EP2320908B1 Dolutegravir Prodrugs
12/25/2013EP2305678B1 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof
12/25/2013EP2292625B1 Substituted spiro compounds and their use for producing pain-relief medicaments
12/25/2013EP2269589B1 Ion binding polymers and uses thereof
12/25/2013EP2248812B1 Fused cyclic compounds as gpr40 receptor modulators
12/25/2013EP2214683B9 Unit dosage for brain health
12/25/2013EP2211620B1 3-PYRAZIN SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AS JANUS KINASE INHIBITORS FOR THE TREATMENT OF CANCER DISEASES
12/25/2013EP2208721B1 Histone deacetylase inhibitor, composition and use thereof
12/25/2013EP2194043B1 Processes
12/25/2013EP2186789B1 Method of producing reduced coenzyme q10 and method of stabilizing the same
12/25/2013EP2185158B1 Use of phosphatidylcholine for treating steroid-dependent and steroid-refractory ulcerative colitis
12/25/2013EP2176211B1 Pleuromutilin derivatives
12/25/2013EP2173707B1 Pleuromutilin derivatives and their use as antimicrobials
12/25/2013EP2167085B1 4- [2- (4-methylphenylsulfanyl) phenyl]piperidine for the treatment of irritable bowel syndrome (ibs)
12/25/2013EP2163553B1 Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof
12/25/2013EP2153870B1 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
12/25/2013EP2145957B1 Compositions for enhancing delivery of double-stranded RNA to regulate gene expression in mammalian cells
12/25/2013EP2142529B1 Trpv1 antagonists and uses thereof
12/25/2013EP2139882B1 3- substituted quinoline or quinoxaline derivatives and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors
12/25/2013EP2139843B1 Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators
12/25/2013EP2117525B1 Use of 1-phenyl-3-dimethylamino-propane compounds for the therapy of neuropathy pain
12/25/2013EP2097413B1 2-[(2-substituted)-ind0lizin-3-yl]-2-oxo-acetamide derivatives as antifungal agents
12/25/2013EP2097394B1 1,2,4-triazole derivatives as sigma receptor inhibitors
12/25/2013EP2086539B1 Selective glycosidase inhibitors
12/25/2013EP2083831B1 Method of treatment using fatty acid synthesis inhibitors
12/25/2013EP2068871B1 Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and the use for nonsense suppression
12/25/2013EP2056827B1 Method for inducing tumor apoptosis by increasing nitric oxide levels
12/25/2013EP2053919B1 Method of reducing neuronal cell damage
12/25/2013EP2043653B1 Crystalline forms of gemcitabine amide prodrug, compositions and use thereof
12/25/2013EP2026787B1 Tablet formulation comprising repaglinide and metformin
12/25/2013EP1991554B1 Thiopyrophosphate organic compounds, method for preparing thereof and compositions containing them
12/25/2013CN203354929U Drug delivery plaster for reduction of bleeding amount in operation
12/25/2013CN1901920B Food composition comprising glucosamine
12/25/2013CN103477228A Novel pancreatic cancer biomarker using the characteristics of pancreatic cancer stem cells, and use thereof
12/25/2013CN103476947A Enhanced biodistribution of oligomers
12/25/2013CN103476932A Nucleic acid modulators of CLEC-2
12/25/2013CN103476801A Cellulose-based nanoparticles for drug delivery
12/25/2013CN103476777A Novel heterocyclic derivatives
12/25/2013CN103476776A 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitors
12/25/2013CN103476773A New azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
12/25/2013CN103476772A Novel oxazolidinone derivative and medical composition containing same
12/25/2013CN103476771A IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation
12/25/2013CN103476770A Novel salts and polymorphic forms of afatinib
12/25/2013CN103476769A Novel anti-cancer agents
12/25/2013CN103476768A 6,5-heterocyclic propargylic alcohol compounds and uses therefor
12/25/2013CN103476766A Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
12/25/2013CN103476765A Method of inhibiting hamartoma tumor cells
12/25/2013CN103476760A 1,4-oxazepines as BACE1 and/or BACE2 inhibitors
12/25/2013CN103476759A Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines
12/25/2013CN103476757A Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A)
12/25/2013CN103476756A 3-ureidoisoquinolin-8-yl derivatives
12/25/2013CN103476755A Compounds and methods
12/25/2013CN103476753A Novel rebamipide complexes and cocrystals
12/25/2013CN103476746A Novel modulators of cortical dopaminergic- and NMDA-receptor-mediated glutamatergic neurotransmission
12/25/2013CN103476744A Diazeniumdiolate derivatives
12/25/2013CN103476457A Veterinary anti-prolactin composition for ruminants
12/25/2013CN103476432A Process for producing aqueous solution containing fat-soluble substance
12/25/2013CN103476431A Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof
12/25/2013CN103476421A Composition, glucose metabolism-improving agent, and method for improving glucose metabolism
12/25/2013CN103476419A Pharmaceutical compositions of iron for oral administration
12/25/2013CN103476418A Sulphated arabinogalactans, apiogalacturonans and sulphated heteroglycans for treating diseases caused by the influenza virus
12/25/2013CN103476417A Compounds and methods of treating diabetes
12/25/2013CN103476416A Compounds and methods for treatment of hypertension
12/25/2013CN103476415A CBP/catenin antagonists for enhancing asymmetric division of somatic stem cells
12/25/2013CN103476413A Combinations
12/25/2013CN103476412A Aclidinium for use in improving the quality of sleep in respiratory patients
12/25/2013CN103476411A Targeting human thymidylate kinase induces dna repair toxicity in malignant tumor cells
12/25/2013CN103476410A Combination therapy
12/25/2013CN103476409A Alisporivir to treat hepatitis C virus infection
12/25/2013CN103476408A Use of compounds isolated from morus bark
12/25/2013CN103476407A Treatment of HER2-positive cancer with paclitaxel and trastuzumab-MCC-DM1
12/25/2013CN103476405A Therapeutic agent for diastolic congestive heart failure
12/25/2013CN103476403A Controlled release formulations of opioids
12/25/2013CN103476402A Lisuride, terguride and derivatives thereof for use in the prophylaxis and/or treatment of fibrotic changes
12/25/2013CN103476400A Formulations comprising 2-amino-2-[2-(4 - octylphenyl) ethyl] propane -1, 3-diol
12/25/2013CN103476398A Menthol liquids composition
12/25/2013CN103476397A Process for preparing pharmaceutical formulation in form of antioxidant-free solution for injection containing pemetrexed or its salt
1 ... 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 ... 7860